Results 221 to 230 of about 59,250 (306)

PRDM1 Knockdown Promotes Ferroptosis and Sunitinib Sensitivity by Modulating the PI3K/Akt Signaling Through Inhibition of ESM1 Transcription in Renal Cell Carcinoma

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Renal cell carcinoma (RCC) is a commonly occurring and considerable burden on public health. Although chemotherapy benefits patients with advanced RCC, sunitinib resistance leads to a poor prognosis. Ferroptosis is also involved in sunitinib resistance in RCC.
Yi‐Shuai Zhang, Xin‐Qi Pei, Ji‐Ping Sun, Chen‐Hui Ma, Xin‐Yang Wang, Xu‐Dong Li   +5 more
wiley   +1 more source

Effect of a patient decision aid on shared decision making in patients with differentiated thyroid cancer: a randomized controlled trial. [PDF]

Oncologist
Koot A, Ottevanger P, Hermens R, Aarts A, Walraven J, Bonenkamp H, de Wilt J, Nieuwenhuijzen G, van der Veen A, Keemers M, Zandee W, Blanken C, van Aken M, Donders R, Stalmeier P, Netea-Maier R, COMBO study group .   +16 more
europepmc   +1 more source

Development and External Validation of a Postoperative Risk Score for Venous Thromboembolism in Epithelial Ovarian Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a major complication in women with epithelial ovarian cancer (EOC). We aimed to develop and externally validate an early postoperative risk score to identify EOC patients at increased risk of VTE after debulking surgery.
Qiu‐Lin Cui, Yu‐Shi He, Xuan‐Hui Wang, Cheng Li, Gang Wang, Ming Chen, Shu‐Min Chen   +6 more
wiley   +1 more source

Chronotherapeutic optimization of radioactive iodine therapy in differentiated thyroid cancer: The rationale for evening administration. [PDF]

World J Exp Med
Meristoudis G, Savvidis C, Ilias I.
europepmc   +1 more source

Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple‐Positive Breast Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT To identify the determinants of the response to neoadjuvant systemic therapy (NST) in triple‐positive breast cancer (TPBC), we retrospectively enrolled 520 patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who were treated at The First Affiliated Hospital of Chongqing Medical University between January 2015 ...
Lin‐Rui Miao, Hao Liu, Hai‐Ying Yu, Jian Chen, Ming‐Yu Yang, Ya‐Lan Zhang, Gang Tu, Ling‐Feng Tang   +7 more
wiley   +1 more source

Conditional survival and prognostic nomogram for distant metastatic differentiated thyroid cancer after total thyroidectomy. [PDF]

Sci Rep
Guo H, Qi Y, Zhang J, Wu J, Sun C.
europepmc   +1 more source

The Regulatory Role and Mechanism of Myoferlin in Mitophagy During Papillary Thyroid Carcinogenesis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Papillary thyroid carcinoma (PTC) is the most prevalent subtype of thyroid cancer; however, the regulatory mechanisms by which mitophagy influences its progression remain inadequately elucidated. This study sought to examine the role of myoferlin (MYOF) in mitophagy and its molecular basis during PTC development. Utilizing three paired PTC and
Wen‐Chao Lyu, Yang‐Shuai Wang, Chun‐Yang Shang, Ming Qi, Tong‐Chang Li, Li‐Xin Lian, Hai‐Quan Qiao   +6 more
wiley   +1 more source

Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi-Center Retrospective Cohort. [PDF]

Head Neck
Kampel L, Edalati S, Yosefof E, Warshavsky A, Horowitz G, Muhanna N, Shoffel-Havakuk H, Robenshtok E, Popovtzer A, Finkel I.   +9 more
europepmc   +1 more source

BRAF and MEK inhibitors in the treatment of aggressive thyroid carcinomas

, 2008
Salerno, Paolo
core  

Single status shows age dependent bidirectional effects in differentiated thyroid cancer. [PDF]

Sci Rep
Xiao X, Zhou R, Dou X, Ouyang H, Li X, Xia F, Ouyang X, Li S, Li C.   +8 more
europepmc   +1 more source